Blog

Dedicated to Life Science Research & Drug Development

ZEAB Therapeutic welcomes Dr John Patrick Alao

ZEAB Therapeutic is glad to welcome Dr John Patrick Alao as our new Senior Scientist! Dr John Patrick obtained his undergraduate degree in Biochemistry from the University of East London, followed by a PhD at Imperial College London.


11/01/2021 0

PhD level Microbiologist, Immunologist, Biochemist

  Job Title: PhD level Microbiologist, Immunologist, Biochemist Location: Alexandra Lounge, Maryland USA Job Grade: (as Post-Doctoral Researchers) Job Number:105102021 School/Service: COVID-19 Testing and investigation Application Deadline: 31st January 2021 Responsible to Dr Bene Afolabi   Job Description We are seeking a highly motivated postdoctoral fellow to join the project managed by ZEAB Therapeutic under…
Read more


06/01/2021 0

Recent Job Openings

Job Vacancy is now closed, please check back in April 2021 for other job openings.


29/05/2020 0

ZEAB Therapeutic welcomes Dr Onyin Udo-Chijoke

Dr Onyin is bringing her wealth of knowledge and experience in invivo research and nano-particle drug delivery from Aston University, Birmingham, UK. As a biochemistry graduate from Covenant University, Nigeria, she brings with her numerous research presentations at UKPharmSci, MIBio coherence and UKICRS (to mention a few). ZEAB is excited to have her join our…
Read more


22/08/2019 0

ZEAB Therapeutic official opening

ZEAB was pleased to have Dr Winston Morgan, a Reader in Toxicology and Clinical Biochemistry at University of East London, attend and speak at the official opening.


31/05/2019 0

Ongoing Investigation

ZEAB Therapeutic LTD is currently carrying out drug development activities for the treatment of colorectal cancer with a patent application. The activities include ADME Investigation (in-silico, in-vitro and ex-vivo) in collaboration with reputable institutions (University of East London U.K., BIDMC – Harvard Medical School, U.S.A.) ZEAB Therapeutic is also engaging the services of Cresset Discovery…
Read more


03/05/2019 0